SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Gilead Expands Remdesivir Licensing to Filovirus Disease

Gilead expanded its voluntary remdesivir licensing agreements to include filovirus disease.

GILD

Related stories